Martin Brändle
Investor Relations Contact at TECAN GROUP AG
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Andreas Wilhelm | M | 55 | 20 years | |
Ulrich Kanter | M | 61 | 10 years | |
Lukas Braunschweiler | M | 68 | 10 years | |
Achim von Leoprechting | M | 56 | 11 years | |
Daniel Marshak | M | 67 | 6 years | |
Ingrid Pürgstaller | F | 44 | 4 years | |
Ralf Griebel | M | 52 | 4 years | |
Myra Eskes | F | - | 2 years | |
Tania Micki | F | 52 | 4 years | |
Erik Norström | M | 50 | 7 years | |
Klaus Lun | M | 52 | 11 years | |
Christa Kreuzburg | M | 65 | 11 years | |
Günter Weisshaar | M | 64 | 21 years | |
Wael Yared | M | 62 | 5 years | |
Oliver Fetzer | M | 60 | 13 years | |
Karen Hübscher | M | 61 | 12 years | |
Matthias Gillner | M | 57 | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Martin Brusdeilins | M | 72 | 3 years | |
Mirko Scherer | M | 55 |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | 10 years |
Markus Schmid | M | 56 | 9 years | |
Thomas Werner Bachmann | M | 65 | 7 years | |
Carl Severinghaus | M | 71 | 19 years | |
Peter Ryser | M | 72 | 7 years | |
Gérard Vaillant | M | 82 | 14 years | |
Rolf Classon | M | 79 | 9 years | |
Frederic Vanderhaegen | M | 57 | 4 years | |
Stefan Traeger | M | 57 | 4 years | |
Bernhard Grob | M | 68 | - | |
Domingo Messerli | M | 65 | 2 years | |
Stephen M. Levers | M | 70 | 13 years | |
Rudolf Eugster | M | 59 | 18 years | |
Klaus Godl | M | - |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | 1 years |
Matthew Robin | M | 59 | 3 years | |
Lars Erik Holmqvist | M | 64 | - | |
Heinrich Fischer | M | 74 | 16 years | |
Lesley A. Stolz | M | 60 |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | 4 years |
Brent Hatzis-Schoch | M | 59 |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | 6 years |
David Roy Martyr | M | 67 | 7 years | |
Erik Walldén | M | 75 | 4 years | |
Thomas E. Needham | M | 60 |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | - |
Dominique F. Baly | M | 76 | 4 years | |
Jim Frates | M | 56 |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | 5 years |
Michael R. Baroni | M | 69 | - | |
Alfred Bowie | M | - | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
Switzerland | 38 | 86.36% |
Germany | 6 | 13.64% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Martin Brändle
- Personal Network